{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:24:10Z","timestamp":1790565850329,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.xcrm.2026.102864","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:02:15Z","timestamp":1784646135000},"page":"102864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Discovery of a peripherally restricted \u03b12AAR agonist as a safe and broad-spectrum oral analgesic"],"prefix":"10.1016","volume":"7","author":[{"given":"Zhiqiang","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102864_bib1","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","article-title":"Opioid epidemic in the United States","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.xcrm.2026.102864_bib2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrd.2017.87","article-title":"Breaking barriers to novel analgesic drug development","volume":"16","author":"Yekkirala","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102864_bib3","series-title":"Development of Non-opioid Analgesics for Chronic Pain: Guidance for Industry (Draft Guidance)","year":"2025"},{"key":"10.1016\/j.xcrm.2026.102864_bib4","article-title":"Clinical pain management: Current practice and recent innovations in research","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.102864_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102864_bib6","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/s41467-025-57136-7","article-title":"Virtual library docking for cannabinoid-1 receptor agonists with reduced side effects","volume":"16","author":"Tummino","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102864_bib7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s40265-025-02178-w","article-title":"Suzetrigine: First Approval","volume":"85","author":"Keam","year":"2025","journal-title":"Drugs"},{"key":"10.1016\/j.xcrm.2026.102864_bib8","first-page":"1085","article-title":"Suzetrigine, a Nonopioid Na V 1.8 Inhibitor for Treatment of Moderate-to-severe Acute Pain: Two Phase 3 Randomized Clinical Trials","volume":"142","author":"Bertoch","year":"2025","journal-title":"Anesthesiology"},{"key":"10.1016\/j.xcrm.2026.102864_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2344\/0003-3006-62.1.31","article-title":"Alpha-2 adrenergic receptor agonists: a review of current clinical applications","volume":"62","author":"Giovannitti","year":"2015","journal-title":"Anesth. Prog."},{"key":"10.1016\/j.xcrm.2026.102864_bib10","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.pain.2012.04.014","article-title":"Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy","volume":"153","author":"Campbell","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.xcrm.2026.102864_bib11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/clpt.1988.44","article-title":"Association of pain relief with drug side effects in postherpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen, and placebo","volume":"43","author":"Max","year":"1988","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.xcrm.2026.102864_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/JCI191346","article-title":"Mechanism-based nonopioid analgesic targets","volume":"135","author":"Zeng","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102864_bib13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0304-3959(94)00209-W","article-title":"Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group","volume":"61","author":"Eisenach","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.xcrm.2026.102864_bib14","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/00000542-199312000-00005","article-title":"Epidural clonidine treatment for refractory reflex sympathetic dystrophy","volume":"79","author":"Rauck","year":"1993","journal-title":"Anesthesiology"},{"key":"10.1016\/j.xcrm.2026.102864_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0304-3959(99)00286-9","article-title":"The alpha(2A) adrenoceptor and the sympathetic postganglionic neuron contribute to the development of neuropathic heat hyperalgesia in mice","volume":"85","author":"Kingery","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.xcrm.2026.102864_bib16","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1111\/bph.14580","article-title":"Spinal alpha(2) -adrenoceptors and neuropathic pain modulation; therapeutic target","volume":"176","author":"Bahari","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.102864_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/science.abn7065","article-title":"Structure-based discovery of nonopioid analgesics acting through the \u03b1(2A)-adrenergic receptor","volume":"377","author":"Fink","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102864_bib18","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2500006122","article-title":"Discovery and development of an oral analgesic targeting the \u03b12B adrenoceptor","volume":"122","author":"Toyomoto","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102864_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-025-08618-7","article-title":"A cryptic pocket in CB1 drives peripheral and functional selectivity","volume":"640","author":"Rangari","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102864_bib20","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/ejp.629","article-title":"Effects of centrally acting analgesics on spinal segmental reflexes and wind-up","volume":"19","author":"Mazo","year":"2015","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.xcrm.2026.102864_bib21","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jtcvs.2013.07.043","article-title":"Dexmedetomidine, an alpha-2a adrenergic agonist, promotes ischemic tolerance in a murine model of spinal cord ischemia-reperfusion","volume":"147","author":"Bell","year":"2014","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.xcrm.2026.102864_bib22","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/sj.mp.4001605","article-title":"Association and linkage of alpha-2A adrenergic receptor gene polymorphisms with childhood ADHD","volume":"10","author":"Park","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.xcrm.2026.102864_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj5347","article-title":"Structural insights into ligand recognition, activation, and signaling of the alpha(2A) adrenergic receptor","volume":"8","author":"Xu","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2026.102864_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/10611860310001648248","article-title":"Classification analysis of P-glycoprotein substrate specificity","volume":"11","author":"Didziapetris","year":"2003","journal-title":"J. Drug Target."},{"key":"10.1016\/j.xcrm.2026.102864_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fpain.2022.1112614","article-title":"Investigations into an overlooked early component of painful nociceptive withdrawal reflex responses in humans","volume":"3","author":"Thorell","year":"2023","journal-title":"Front. Pain Res."},{"key":"10.1016\/j.xcrm.2026.102864_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1297931","article-title":"The role of neuroinflammation in the transition of acute to chronic pain and the opioid-induced hyperalgesia and tolerance","volume":"14","author":"Echeverria-Villalobos","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.102864_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrn2533","article-title":"Pathological and protective roles of glia in chronic pain","volume":"10","author":"Milligan","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.xcrm.2026.102864_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41392-024-01845-w","article-title":"Pathology of pain and its implications for therapeutic interventions","volume":"9","author":"Cao","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2026.102864_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41586-022-04777-z","article-title":"Neuropathic pain caused by miswiring and abnormal end organ targeting","volume":"606","author":"Gangadharan","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102864_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.xcrm.2026.102864_bib31","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature08505","article-title":"Injury-induced mechanical hypersensitivity requires C-low threshold mechanoreceptors","volume":"462","author":"Seal","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102864_bib32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00000542-199701000-00024","article-title":"Synergistic antinociceptive interactions of morphine and clonidine in rats with nerve-ligation injury","volume":"86","author":"Ossipov","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1016\/j.xcrm.2026.102864_bib33","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0022-3565(24)38063-2","article-title":"Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine","volume":"288","author":"Fairbanks","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.xcrm.2026.102864_bib34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/j.pain.0000000000002688","article-title":"Combination pharmacotherapy for the treatment of neuropathic pain in adults: systematic review and meta-analysis","volume":"164","author":"Balanaser","year":"2023","journal-title":"Pain"},{"key":"10.1016\/j.xcrm.2026.102864_bib35","doi-asserted-by":"crossref","first-page":"8533","DOI":"10.1038\/s41467-025-62618-9","article-title":"Challenges to determine synergistic drug interactions in mice","volume":"16","author":"Westerman","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102864_bib36","article-title":"Evaluation of synergism in drug combinations and reference models for future orientations in oncology","volume":"3","author":"Duarte","year":"2022","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102864_bib37","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1097\/01.blo.0000093059.96273.56","article-title":"Bone cancer pain","volume":"415","author":"Clohisy","year":"2003","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.xcrm.2026.102864_bib38","first-page":"286","article-title":"Opioid analgesics for nociceptive cancer pain: A comprehensive review","volume":"74","author":"Abdel Shaheed","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2026.102864_bib39","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/rapm-2020-101779","article-title":"Role of peripheral sensory neuron mu-opioid receptors in nociceptive, inflammatory, and neuropathic pain","volume":"45","author":"Barpujari","year":"2020","journal-title":"Reg. Anesth. Pain Med."},{"key":"10.1016\/j.xcrm.2026.102864_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106560","article-title":"Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of anti-retroviral toxic neuropathy","volume":"187","author":"Carey","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.xcrm.2026.102864_bib41","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/j.pain.0000000000002502","article-title":"A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse","volume":"163","author":"Lin","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.xcrm.2026.102864_bib42","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1021\/acsmedchemlett.2c00237","article-title":"Discovery of kappa Opioid Receptor (KOR)-Selective d-Tetrapeptides with Improved In Vivo Antinociceptive Effect after Peripheral Administration","volume":"13","author":"Stefanucci","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.xcrm.2026.102864_bib43","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/ALN.0000000000002191","article-title":"Peripherally Acting mu-Opioid Receptor Agonists Attenuate Ongoing Pain-associated Behavior and Spontaneous Neuronal Activity after Nerve Injury in Rats","volume":"128","author":"Tiwari","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.xcrm.2026.102864_bib44","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1054\/jpai.2000.9435","article-title":"Effectiveness of tizanidine in neuropathic pain: an open-label study","volume":"1","author":"Semenchuk","year":"2000","journal-title":"J. Pain"},{"key":"10.1016\/j.xcrm.2026.102864_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.celrep.2017.06.024","article-title":"Time-Resolved Fast Mammalian Behavior Reveals the Complexity of Protective Pain Responses","volume":"20","author":"Browne","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102864_bib46","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2019.0368","article-title":"Discrimination between nociceptive reflexes and more complex responses consistent with pain in crustaceans","volume":"374","author":"Elwood","year":"2019","journal-title":"Phil. Trans. R. Soc. B."},{"key":"10.1016\/j.xcrm.2026.102864_bib47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0006-8993(85)90719-X","article-title":"Studies on pain. Effects of morphine on a spinal nociceptive flexion reflex and related pain sensation in man","volume":"331","author":"Willer","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.xcrm.2026.102864_bib48","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1038\/s41467-023-40524-2","article-title":"Structural basis of agonist specificity of alpha(1A)-adrenergic receptor","volume":"14","author":"Su","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102864_bib49","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/CIRCRESAHA.113.300308","article-title":"Adrenergic nervous system in heart failure: pathophysiology and therapy","volume":"113","author":"Lymperopoulos","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.xcrm.2026.102864_bib50","doi-asserted-by":"crossref","first-page":"7157","DOI":"10.1523\/JNEUROSCI.17-18-07157.1997","article-title":"The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy","volume":"17","author":"Stone","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.xcrm.2026.102864_bib51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pneurobio.2006.08.001","article-title":"Noradrenergic pain modulation","volume":"80","author":"Pertovaara","year":"2006","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.xcrm.2026.102864_bib52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/ph14020077","article-title":"Peripheral Mechanisms of Neuropathic Pain-the Role of Neuronal and Non-Neuronal Interactions and Their Implications for Topical Treatment of Neuropathic Pain","volume":"14","author":"Kocot-K\u0119pska","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.xcrm.2026.102864_bib53","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2147\/JPR.S159729","article-title":"Prevalence of central and peripheral neuropathic pain in patients attending pain clinics in Spain: factors related to intensity of pain and quality of life","volume":"11","author":"Failde","year":"2018","journal-title":"J. Pain Res."},{"key":"10.1016\/j.xcrm.2026.102864_bib54","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41586-025-08735-3","article-title":"Characterization of single neurons reprogrammed by pancreatic cancer","volume":"640","author":"Thiel","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102864_bib55","article-title":"Targeting molecular pathways in neuropathic cancer pain: from mechanisms to novel therapeutics","volume":"29","author":"Xu","year":"2026","journal-title":"iScience"},{"key":"10.1016\/j.xcrm.2026.102864_bib56","article-title":"Cancer Neuroscience: Decoding Neural Circuitry in Tumor Evolution for Targeted Therapy","volume":"12","author":"Yuan","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.xcrm.2026.102864_bib57","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-025-02241-8","article-title":"Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications","volume":"10","author":"Pu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2026.102864_bib58","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41586-025-10028-8","article-title":"Tumour-brain crosstalk restrains cancer immunity via a sensory-sympathetic axis","volume":"650","author":"Wei","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102864_bib59","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41586-023-06110-8","article-title":"Tumour immune rejection triggered by activation of alpha2-adrenergic receptors","volume":"618","author":"Zhu","year":"2023","journal-title":"Nature"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126002818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126002818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T20:20:50Z","timestamp":1784924450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126002818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2666379126002818"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102864","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a peripherally restricted \u03b12AAR agonist as a safe and broad-spectrum oral analgesic","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102864","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102864"}}